These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 28049204)
21. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity. Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458 [TBL] [Abstract][Full Text] [Related]
22. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions. Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998 [TBL] [Abstract][Full Text] [Related]
24. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol. Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272 [TBL] [Abstract][Full Text] [Related]
25. Desensitization for hypersensitivity reactions to medications. del Carmen Sancho M; Breslow R; Sloane D; Castells M Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865 [TBL] [Abstract][Full Text] [Related]
26. 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study. Takase N; Matsumoto K; Onoe T; Kitao A; Tanioka M; Kikukawa Y; Yamaguchi S; Fujiwara K; Negoro S Int J Clin Oncol; 2015 Jun; 20(3):566-73. PubMed ID: 25030546 [TBL] [Abstract][Full Text] [Related]
27. [Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures]. Brault F; Waton J; Poreaux C; Schmutz JL; Barbaud A Ann Dermatol Venereol; 2017 Nov; 144(11):685-695. PubMed ID: 28760501 [TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization. Wong JT; Ling M; Patil S; Banerji A; Long A J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767 [TBL] [Abstract][Full Text] [Related]
29. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity. Limsuwan T; Castells MC Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753 [TBL] [Abstract][Full Text] [Related]
31. Hypersensitivity to tetracyclines: Skin testing, graded challenge, and desensitization regimens. Maciag MC; Ward SL; O'Connell AE; Broyles AD Ann Allergy Asthma Immunol; 2020 Jun; 124(6):589-593. PubMed ID: 32087343 [TBL] [Abstract][Full Text] [Related]
32. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management. Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233 [TBL] [Abstract][Full Text] [Related]
33. A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions. Patil SU; Long AA; Ling M; Wilson MT; Hesterberg P; Wong JT; Banerji A J Allergy Clin Immunol; 2012 Feb; 129(2):443-7. PubMed ID: 22099941 [TBL] [Abstract][Full Text] [Related]
34. Assessment of Antihistamines and Corticosteroids as Premedication in Rapid Drug Desensitization to Paclitaxel: Outcomes in 155 Procedures. Lopez-Gonzalez P; Madrigal-Burgaleta R; Carpio-Escalona LV; Bernal-Rubio L; Guerra E; Berges-Gimeno MP; Alvarez-Cuesta E J Allergy Clin Immunol Pract; 2018; 6(4):1356-1362. PubMed ID: 29248386 [TBL] [Abstract][Full Text] [Related]
35. Skin test protocol for the prevention of hypersensitivity reactions to oxaliplatin. Pagani M; Bonadonna P Anticancer Res; 2014 Jan; 34(1):537-40. PubMed ID: 24403513 [TBL] [Abstract][Full Text] [Related]
36. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist. Khan DA Ann Allergy Asthma Immunol; 2016 Aug; 117(2):115-20. PubMed ID: 27499538 [TBL] [Abstract][Full Text] [Related]
37. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization. Castells M; Sancho-Serra Mdel C; Simarro M Cancer Immunol Immunother; 2012 Sep; 61(9):1575-84. PubMed ID: 22576054 [TBL] [Abstract][Full Text] [Related]
38. Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes. Isabwe GAC; Garcia Neuer M; de Las Vecillas Sanchez L; Lynch DM; Marquis K; Castells M J Allergy Clin Immunol; 2018 Jul; 142(1):159-170.e2. PubMed ID: 29518427 [TBL] [Abstract][Full Text] [Related]
39. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review. Picard M; Castells MC Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483 [TBL] [Abstract][Full Text] [Related]
40. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Feldweg AM; Lee CW; Matulonis UA; Castells M Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]